Investor Presentation Baird Healthcare Conference September 9, 2015

whitePaper | November 19, 2022

Input from the report was wide ranging. But the consistent theme revolved around compelling reasons why hospitals and healthcare risk managers must adapt and be proactive in developing.

whitePaper | March 17, 2021

To achieve personalization in healthcare for the masses, overcoming specific challenges are needed in order to build a system where all children born today can have access to the best healthcare available.Mass Personalization for Medical Device Therapy tells us on how to Go from Successfully Treating One Patient to One Million

whitePaper | May 18, 2022

Post-COVID conditions, also known by such terms as long COVID and post-acute sequelae of COVID-19, have become an issue of growing national concern. Until recently, researchers were limited by the lack of a specific ICD-10 diagnosis code for post-COVID conditions.

whitePaper | November 24, 2022

The life sciences industry has been exploring ways to accelerate the study start up process for well over a decade. The industry has long understood the value behind faster clinical trials: the sooner clinical trial results can be delivered to agencies

whitePaper | January 13, 2020

Today, healthcare organizations are witnessing a major shift in power. The industry is realigning itself increasingly around the priorities of patients. The change is unstoppable — and healthcare companies must act swiftly to avoid getting left behind.

whitePaper | February 11, 2022

We are living through the greatest challenge our health and care system has ever faced. The Coronavirus (Covid-19) pandemic caused an unprecedented external shock,